Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Inventory Average (2016 - 2025)

Dexcom (DXCM) has disclosed Inventory Average for 12 consecutive years, with $616.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average rose 9.24% to $616.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $616.6 million, a 9.24% increase, with the full-year FY2025 number at $585.8 million, up 6.31% from a year prior.
  • Inventory Average was $616.6 million for Q4 2025 at Dexcom, up from $587.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $616.6 million in Q4 2025 to a low of $308.8 million in Q4 2022.
  • A 3-year average of $530.3 million and a median of $574.4 million in 2024 define the central range for Inventory Average.
  • Biggest YoY gain for Inventory Average was 9.24% in 2025; the steepest drop was 9.24% in 2025.
  • Dexcom's Inventory Average stood at $308.8 million in 2022, then surged by 82.76% to $564.4 million in 2024, then grew by 9.24% to $616.6 million in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Inventory Average are $616.6 million (Q4 2025), $587.4 million (Q3 2025), and $564.4 million (Q4 2024).